A $2 billion government investment to bring Moderna to Australia is paying dividends before a vaccine has rolled off its Melbourne production line, according to the US pharmaceutical giant, as scrutiny lingers around the landmark deal. The company will on Tuesday release a report claiming the new domestic capability will help Australia avoid $4.8 billion…

The post Moderna’s ‘sweetheart’ manufacturing deal starts to deliver appeared first on InnovationAus.com.

This post was originally published on InnovationAus.com.